Related Experiment Video

Updated: Aug 17, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Recombinant p21 protein inhibits lymphocyte proliferation and transcription factors

Ashwani K Khanna1, Matthew Plummer, Vani Nilakantan

  • 1Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA. akkhanna@mcw.edu

Journal of Immunology (Baltimore, Md. : 1950)
|June 10, 2005
PubMed

Insights

Recombinant p21 protein, delivered directly, inhibits cell proliferation and inflammation. This offers a novel therapeutic strategy for cancer, autoimmune diseases, and atherosclerosis.

Area of Science:

  • Cellular and Molecular Biology
  • Immunology
  • Oncology

Background:

  • Aberrant cellular proliferation is central to inflammation, immune disorders, cancer, and atherosclerosis.
  • Cyclin-dependent kinase inhibitor p21 is crucial for cell cycle control.
  • Effective therapeutic strategies require direct delivery of p21 to target cells.

Purpose of the Study:

  • To investigate the intracellular localization and functional effects of a protein-transducing domain-conjugated p21 protein.
  • To assess the potential of direct p21 delivery for controlling aberrant proliferation and inflammation.

Main Methods:

  • Utilized a recombinant p21 protein fused with a protein-transducing domain.
  • Examined nuclear localization and interaction with transcription factors NF-kappaB and NFATs (NFATc, NFATp).
  • Assessed inhibition of lymphocyte proliferation and pro-inflammatory cytokine expression in vitro.

Main Results:

  • The p21 protein successfully localized to cellular nuclear compartments.
  • p21 protein demonstrated interaction with key transcription factors NF-kappaB and NFATs.
  • Significant inhibition of lymphocyte proliferation and pro-inflammatory cytokine production was observed.

Conclusions:

  • Direct delivery of recombinant p21 protein is feasible and effective.
  • p21 protein can modulate key signaling pathways involved in proliferation and inflammation.
  • This approach presents a promising therapeutic avenue for proliferative and inflammatory diseases.

More Related Videos

Inducible and Reversible Dominant-negative (DN) Protein Inhibition08:35

Inducible and Reversible Dominant-negative (DN) Protein Inhibition

Published on: January 7, 2019

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...